Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
End-to-end platform for content validation and sales force readiness.
AI-powered congress engagement coordinator.
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
Join the Viseven team and grow your career with us
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
Let’s network at REpharmaUSA Join the event that brings together over 100 speakers dedicated to timely delivering life-saving treatments to patients. Don’t miss out on the opportunity to network with the attendees from Viseven, including Oksana Matviienko, Regional Director, and Leonardo Sanchez, AE Lead, at booth number 302. We are eager to engage in discussions […]
Let’s connect at Adobe Summit Network with Viseven’s team, including Roman Vasylenko, CTO, Daniel Atieh, Head of Presales, and Max Samuel Gemma, Account Executive, at booth number 287. We are eager to engage with industry leaders, learn from the best global experts, and discuss our expertise in generative AI and personalized solutions at scale. Adobe […]
Join us at GIANT Health Don’t miss the chance to network with our team in person! Olena Volkova, Regional Director, will share invaluable insights on next-gen technologies for pharma and life sciences on 2024. Catch Olena’s talk on December 5th, 15:45-15:55 on the Future Hospital stage. Nataliya Andreychuk, and Vlad Batala, Account Director, will also […]
A closer look at the most significant topics for the sector It is obvious that pharma cannot neglect the impact of AI. Viseven is co-sponsoring the event, and Viseven CEO, Nataliya Andreychuk participates in a panel discussion of day 1 of the event: Crucial Considerations: Navigating the Ethical Terrain of Privacy, Transparency and Regulation
Connect with us at PanAgora Pharma Planning to visit the event? Meet our team in person. Come and listen to Oksana Matviienko, Regional Director at Viseven USA, who will host a panel titled “Using Modular Content to Personalize Experiences at Scale.” Leonardo Sanchez, Account Manager, and Max Gemma, Account Executive USA, will be available for […]
Let’s Connect at Web Summit Web Summit is one of the world’s most massive tech events that brings 70,000+ attendees, 900+ investors, 800+ speakers, and the world’s top media outlets together to share experience, network, and explore the latest technology trends. 2.600 startups from nearly 100 countries will represent the leading industries, including advertising, content, […]
Viseven is co-sponsoring the event, and Viseven CEO, Nataliya Andreychuk participates in a panel discussion of day 1 of the event: Crucial Considerations: Navigating the Ethical Terrain of Privacy, Transparency and Regulation • Ensuring robust data privacy measures while harnessing the power of AI• Addressing ethical concerns regarding patient data collection, consent, and the potential […]
Global pharma companies appear to hold all the cards in emerging markets — stronger R&D pipelines, higher digital maturity, and the resources to execute at scale. Yet drug accessibility rarely comes down to a single decision at corporate HQ. Behind every market entry lies a more complex reality: localization is not simply translation, and most […]
In pharma, broken processes have a long shelf life. Content workflows are no exception — teams notice the inefficiencies, the duplicated effort, the review cycles that drag on for too long, but the perceived risk of changing anything keeps them from acting on it. The result is a kind of institutional inertia: everyone sees the […]
Would you be okay starting a therapy with a 2.5-star rating for a condition where every moment impacts clinical outcomes? Now imagine coming across a negative patient review, or seeing a trusted HCP publicly question its effectiveness or highlight side effects. Even in oncology, where treatment decisions are guided by HCPs, what patients read online […]
